[1] |
Mauri G, Sartore-Bianchi A, Russo AG, et al. Early-onset colorectal cancer in young individuals[J]. Mol Oncol, 2019, 13(2): 109-131.
|
[2] |
Ren L, Zhu D, Benson AR, et al. Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases[J]. Eur J Surg Oncol, 2020, 46(6): 955-966.
|
[3] |
Qin H, Wu YQ, Lin P, et al. Ultrasound image-based radiomics: an innovative method to identify primary tumorous sources of liver metastases[J]. J Ultrasound Med, 2021, 40(6): 1229-1244.
|
[4] |
Song ZY, Yang D, Liu Y, et al. The influence of radiological “disappearing lesions" on the efficacy and prognosis of patients with colorectal liver metastases undergoing conversion therapy[J]. Gastroenterol Res Pract, 2022, 2022: 2200598.
|
[5] |
高建新, 路夷平. 手术联合化疗治疗结直肠癌肝转移的预后及其影响因素研究[J]. 癌症进展, 2019, 17(9): 1094-1097.
|
[6] |
Villard C, Habib M, Nordenvall C, et al. Conversion therapy in patients with colorectal liver metastases[J]. Eur J Surg Oncol, 2021, 47(8): 2038-2045.
|
[7] |
Fenton HM, Taylor JC, Lodge J, et al. Variation in the use of resection for colorectal cancer liver metastases[J]. Ann Surg, 2019, 270(5): 892-898.
|
[8] |
Noren A, Sandstrom P, Gunnarsdottir K, et al. Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden[J]. Scand J Surg, 2018, 107(4): 294-301.
|
[9] |
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis[J]. Ann Surg, 2018, 267(6): 1047-1055.
|
[10] |
刘恩瑞, 关旭, 郭雅琪, 等. 列线图预测同时性转移结直肠癌患者的生存并构建风险分级系统[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(6): 576-584.
|
[11] |
李伟栋, 杨丽, 邹兴文, 等. 基于列线图的肿瘤风险预测及其效果评价[J]. 肿瘤预防与治疗, 2019, 32(4): 305-310.
|
[12] |
黄凯, 张长乐, 吴文涌, 等. 结肠癌列线图预后风险模型构建: 基于SEER数据库的回顾性研究[J]. 安徽医科大学学报, 2021, 56(2): 299-305.
|
[13] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
[14] |
Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, et al. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review[J]. J Gastrointest Surg, 2017, 21(6): 1076-1085.
|
[15] |
Ruzzenente A, Bagante F, Ratti F, et al. Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases[J]. HPB (Oxford), 2019, 21(9): 1230-1239.
|
[16] |
张果, 张瑞, 陈进宏. 结直肠癌肝转移预后评分系统的现状及临床应用[J]. 岭南现代临床外科, 2021, 21(1): 11-16.
|
[17] |
Tosi F, Magni E, Amatu A, et al. Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis[J]. Clin Colorectal Cancer, 2017, 16(3): e153-e163.
|
[18] |
Midiri G, Amanti C, Consorti F, et al. Usefulness of preoperative CEA levels in the assessment of colorectal cancer patient stage[J]. J Surg Oncol, 1983, 22(4): 257-260.
|
[19] |
Su BB, Shi H, Wan J. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection[J]. World J Gastroenterol, 2012, 18(17): 2121-2126.
|
[20] |
Kim KY, Kim NK, Cha IH, et al. Novel methods for clinical risk stratification in patients with colorectal liver metastases[J]. Cancer Res Treat, 2015, 47(2): 242-250.
|
[21] |
Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis[J]. J Am Coll Surg, 2003, 197(2): 233-241, 241-242.
|
[22] |
朱德祥, 任黎, 许剑民. 中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J]. 中国普通外科杂志, 2023, 32(1): 1-29.
|
[23] |
Jagoditsch M, Lisborg PH, Jatzko GR, et al. Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical, and pathologic variables[J]. World J Surg, 2000, 24(10): 1264-1270.
|
[24] |
Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases[J]. Ann Surg, 1999, 230(3): 309-318, 318-321.
|
[25] |
Ayez N, van der Stok EP, Grunhagen DJ, et al. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator[J]. Eur J Surg Oncol, 2015, 41(7): 859-867.
|